Terms: = Uterine cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
243 results:
1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
2. An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
Mudrinich SM; Nguyen MLT; Blemur DM; Wang X; Wang YF; Krishnamurti U; Mosunjac M; Flowers LC
J Low Genit Tract Dis; 2024 Jan; 28(1):101-106. PubMed ID: 38117565
[TBL] [Abstract] [Full Text] [Related]
3. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
[TBL] [Abstract] [Full Text] [Related]
5. Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous cancers to Widely Invasive Cervical Squamous Cell cancer.
Kashofer K; Reich O; Regauer S
Arch Pathol Lab Med; 2023 Dec; 147(12):1438-1445. PubMed ID: 36800542
[TBL] [Abstract] [Full Text] [Related]
6. Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells.
Saleh T; Khasawneh AI; Himsawi N; Abu-Raideh J; Ejeilat V; Elshazly AM; Gewirtz DA
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555154
[TBL] [Abstract] [Full Text] [Related]
7. Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway.
Song M; Meng Q; Jiang X; Liu J; Xiao M; Zhang Z; Wang J; Bai H
J Cell Mol Med; 2022 Aug; 26(15):4244-4253. PubMed ID: 35775110
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variation of
Jin X; Dai M; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):101-108. PubMed ID: 35545369
[No Abstract] [Full Text] [Related]
9. Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial cancer (ES-EC): A Systematic Review.
Tanos P; Dimitriou S; Gullo G; Tanos V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269800
[TBL] [Abstract] [Full Text] [Related]
10. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer.
Yin L; Zhang Y; Zheng L
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878159
[TBL] [Abstract] [Full Text] [Related]
12. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
Bai H; Song M; Jiao R; Li W; Zhao J; Xiao M; Jin M; Zhang Z; Deng H
J Cell Mol Med; 2021 Oct; 25(19):9306-9318. PubMed ID: 34435746
[TBL] [Abstract] [Full Text] [Related]
13. Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
Goto K; Pissaloux D; Tirode F; de la Fouchardière A
J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
[TBL] [Abstract] [Full Text] [Related]
14. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
[TBL] [Abstract] [Full Text] [Related]
15. Autophagy buffers Ras-induced genotoxic stress enabling malignant transformation in keratinocytes primed by human papillomavirus.
Cararo-Lopes E; Dias MH; da Silva MS; Zeidler JD; Vessoni AT; Reis MS; Boccardo E; Armelin HA
Cell Death Dis; 2021 Feb; 12(2):194. PubMed ID: 33602932
[TBL] [Abstract] [Full Text] [Related]
16. Sirtuin 2 in Endometrial cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway.
Guo Y; Zhao N; Zhou J; Dong J; Wang X
Technol Cancer Res Treat; 2020; 19():1533033820980781. PubMed ID: 33327875
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract] [Full Text] [Related]
19. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
20. Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity.
Boon SS; Xia C; Lim JY; Chen Z; Law PTY; Yeung ACM; Thomas M; Banks L; Chan PKS
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996427
[TBL] [Abstract] [Full Text] [Related]
[Next]
